Literature DB >> 30534428

Transthoracic Needle Biopsy (TNB) under Different Guiding Methods - the Experience of the Thoracic Surgery Clinic of Craiova after the First 235 Cases.

A Demetrian1, A Dobrinescu1, S Bălă2, C Demetrian3, I A Gheonea4, D M Albulescu4.   

Abstract

Transthoracic needle biopsy (TNB) is a fast and safe method used to establish definitive diagnosis for most thoracic lesions, whether the lesion is located in the pleura, the lung parenchyma, or the mediastinum. Diffuse disease and solitary lesions are equally approachable.TNB can avoid (when technically possible) more complex diagnostic interventions such asmediastinoscopy, thoracoscopy and exploratory thoracotomy. This article focuses on the advantages of TNB which is a safe, affordable and quick method to obtain histopathological confirmation of intrathoracic tumors. Material and MethodsThe study included a total of 235 cases over a period of 4 and a half years (01.01.2011-30.04.2015). We investigated the demographic and clinical parameters, the guiding methods, the histological results and the complications of the procedure. ResultsThe median age of the patients was 62 years and the predominent sex was male. We could obtain a tissue biopsy in 99% with a histopathological confirmation of 88%. The most frequently used guiding method was the previous CT scan of the patient and the anathomical landmarks (53%). The main histopathological result was squamous cell carcinoma.ConclusionsTNB is generally a safe procedure with limited morbidity and extremely rare mortality. It is an affordable and quick method to obtain histopathological confirmation of intrathoracic tumors.Most TNBs can be performed by using local anesthesia without conscious sedation and virtually any location in the chest can be safely addressed.

Entities:  

Keywords:  biopsy guns; histopathologicaldiagnosis; thoracic tumors; transthoracic needle biopsy

Year:  2015        PMID: 30534428      PMCID: PMC6246991          DOI: 10.12865/CHSJ.41.03.08

Source DB:  PubMed          Journal:  Curr Health Sci J


Introduction

Transthoracic needle biopsiy has emerged over the past 30 years as the invasive procedure of choicefor diagnosing intrathoracic lesions [1]. The technique has proved extremely accurate in the diagnosis of these lesions. With the advent of cross-sectional imaging using CT and sonography, the applications of TNB have expanded to the diagnosis of mediastinal, hilar, chest wall, and pleural lesions. . Diffuse disease and solitary lesions are equally approachable. TNB can avoid (when technically possible) more complex diagnostic interventions such asmediastinoscopy, thoracoscopy and exploratory thoracotomy. This article focuses on the advantages of TNB which is a safe, affordable and quick method to obtain histopathological confirmation of intrathoracic tumors. The instruments used are biopsy guns or needles of varying gauge, lengths, tip configurations, and firing mechanisms. The needle selection depends upon lesion characteristics, type/amount of tissue required, and operator preference.

Material and Methods

The study included a total of 235 consecutive cases of intrathoracic tumors over a period of 4 and a half years (01.01.2011-30.04.2015) in whom a transthoracic needle biopsy was performed in order to obtain a histopathological result. The guiding method for precise location of the tumor included fluoroscopy (for the first patients of the study), ultrasound, CT scan but mostly a previous CT scan of the patient and the use of anathomical landmarks (what we call a „CT oriented biopsy”). The CT oriented biopsy method was used for the bigger tumors in the proximity of the pleura. In order to certfy the intratumoral location, after the local anesthesia aspiration was performed with the same needle. If no air or blood was aspired into the syringe the intratumoral location was considered to be confirmed and the biopsy was performed following the same trajectory. The instrumentsusedwerebiopsy guns or needles of varying gauge (14 to 20), lengths (20 to 30 mm), tip configurations, and sampling mechanisms (manual or automathic). The needle selection depended upon lesion characteristics and proximity, operator preference and disponibility of the devices. Written informed consent was obtained, including consent for possible chest-tube placement. The patient was informed and educated about the procedure, its benefits, and its risks. A special warning was the powerfull sound of the authomatic needle, in order to avoid the sudden movement of the patient. The next step of the biopsy procedure consists in chosing the trajectory of the needle wich was established by choosing the shortest straight pathway from the skin to the lesion avoiding the vessels (intercostal, subclavian, internal mammary, vena cava and aorta). The skin site is prepped and draped using a sterile technique. Palpation of underlying anathomical landmarks is very helpful. The procedurewasperformedunder local anesthesiaalone (10 ml of lydocain 1%) withoutsedation in all of the cases. For local anesthesia, a 27-gauge needle is used to inject the anesthetic into the skin and subcutaneous tissues, followed by deeper infiltration of the intercostal muscles. The biopsy needle is inserted through the skin into the subcutaneous tissues. During needle insertion, one hand should hold the needle at skin level to stabilize and steer the needle. The other hand should hold the device and push gently downward to advance the needle. After the needle is advanced to the level of the tumor the needle position and angle are verified with a short segment CT scan (only when the CT scan guidance is used). The firing of the biopsy needle is performed during a small period of apnea (3 to 5 seconds) that we request from the patient. 3 to 6 biopsy passages are made using the same trajectory, until we consider that the specimen is adequate for histopathological diagnosis. After the biopsy, a short spiral CT is performed to evaluate for complications such as pneumothorax, hemothorax or intrapulmonary hematoma. If the scan is normal the patient may be discharged in the same day or the next day in few particular cases (dispnea, microhemoptysis, local pain). Usually we do not perform a routine chest X-ray after biopsy unless the clinical signs of complications are revealed.

Results

In the study group of 235 patients the median age was 62 years (ranging from 14 to 86 years) The sex ratio was 3/1 males/females, in accordance with the lung cancer male predominance. We could obtain a tissue sample in 99% of the cases (in 2 patients the rapid onset of a small pneumothorax after local anesthesia made impossible the biopsy). For the rest of 233 patients, a histopathological confirmation was possible in 82%. The tumor location was mainly in the lungs, also few other locations were addressed (1).
Figure 1

Tumor location

Tumor location For the most of the cases (125 – 53%), the guiding method was „CT oriented” as we descriebed it above, due to the big size of the tumor and the proximity to the thoracic wall. The other methods included the CT, ultrasound and fluoroscopy (2). The fluoroscopy was the first method that we used for the only reason of high availability but we had to abandon due to the risk of radiation for the patient and the operator and the imperfect location of the tumor. The ultrasound guidance was also used in few cases but the imperfect location of the profound lesions was the reason to abandon it also.Currently we are using only the CT oriented and the CT guided methods.
Figure 2

Guidance method of the biopsy

Guidance method of the biopsy The histopathological examination revealed mostly squamous cell carcinoma (72 cases) and adenocarcinoma (52 cases) or malignant tumor with no other specification (41 cases) and other histopathological findings to a lesser extent (3). A molecular study of those tumors is in progress.
Figure 3

Histopathological results

Histopathological results We compared the average age of patients with different tumor types using the ANOVA test, and we found that there are highly significant statistical differences between them (p=0.001). Continuing the analysis with post-hoc tests, we established that patients with squamous carcinoma and adenocarcinoma tend to be older than patients with various other pathologies, and that patients with adenocarcinoma also have the average age greater than patients with malignant tumors with no other specification (4, 1).
Figure 4

Comparison of the average age for different tumor types

Table 1

Average age of patients with different tumor types

Tumor type

No. of cases

Mean

St.dev.

Squamous carcinoma

72

63.616

11.326

Adenocarcinoma

52

65.5

13.429

Malignant tumor

41

59.744

12.135

Benign lesion

18

62.24

10.557

Other pathology

24

53.75

8.46

Comparison of the average age for different tumor types Average age of patients with different tumor types Tumor type No. of cases Mean St.dev. Squamous carcinoma 72 63.616 11.326 Adenocarcinoma 52 65.5 13.429 Malignant tumor 41 59.744 12.135 Benign lesion 18 62.24 10.557 Other pathology 24 53.75 8.46 Gender distribution of patients with different tumor types Tumor type/Gender Males Females Squamous carcinoma 55 (76.39%) 17 (23.61%) Adenocarcinoma 40 (76.92%) 12 (23.08%) Malignant tumor 29 (70.73%) 12 (29.27%) Benign lesion 12 (66.67%) 6 (33.33%) Other pathology 16 (66.67%) 8 (33.33%) Comparing the gender distribution of the different tumor types, we encountered small differences, but, overall, they were not statistically significant - the Chi square test result was p=0.775<0.05 (5, 2).
Figure 5

Gender distribution of patients with different tumor types

Table 2

Gender distribution of patients with different tumor types

Tumor type/Gender

Males

Females

Squamous carcinoma

55 (76.39%)

17 (23.61%)

Adenocarcinoma

40 (76.92%)

12 (23.08%)

Malignant tumor

29 (70.73%)

12 (29.27%)

Benign lesion

12 (66.67%)

6 (33.33%)

Other pathology

16 (66.67%)

8 (33.33%)

Gender distribution of patients with different tumor types The most frequent complication that we encountered was the pneumothorax which was minor and was treated conservatively in 14 cases (6%) and significant, requiring chest tube placement in 4 cases (2%). The other complications are detailed in the 1. The mortality of the procedure for the 235 patients was 0. Complication No of cases % Minor pneumothorax Significant pneumothorax Minor hemoptysis Significant hemoptysis Accidental puncture of the liver                                                  (under fluoroscopy guidance) 14 4 10 1 1 6 2 4 0.5 0.5 Analysing the frequency of complications for different guidance methods, we found percentual differences, without any stattistical signification (p Chi square=0.773>0.05), mainly because for two of the four methods used (fluoroscopy and ultrasound), we had a very small number of investigated patiens (6, 4).
Figure 6

Frequency of complications depending on guidance method

Table 4

Frequency of complications depending on guidance method

Guidance

Total

Complications

Complications (%)

CT oriented

125

17

13.60%

CT guided

86

9

10.47%

Fluoroscopy

20

3

15.00%

Ultrasound

4

1

25.00%

Total

235

30

12.77%

Frequency of complications depending on guidance method Guidance Total Complications Complications (%) CT oriented 125 17 13.60% CT guided 86 9 10.47% Fluoroscopy 20 3 15.00% Ultrasound 4 1 25.00% Total 235 30 12.77% Frequency of complications depending on guidance method

Discussion

TNB is a safe minimal invasive procedure leading to histopathological confirmation of intrathoracic tumors, especially valuable in the diagnosis of small pulmonary nodules [2]. Haaga and Alfidi reported the first case of CT-PTNB in 1976 [3] and, since then, CT guided TNB became the procedure of choice for histopathological confirmation of the intrapulmonary lesions. This procedure has several advantages: high true-positive rate [4], minimal invasiveness, low cost and general availability. Sihoe et al. [5]concludedafter a study on 443 consecutive adult patients with a lung mass confirmed or suspected to be an early stage primary lung cancer that proceeding to surgery without preoperative diagnosis in selected patients with a suspicious lung mass is safe and can potentially reduce the interval between presentation and surgical management. However, it is important to exclude a benign lesion in order to avoide unnecessary surgery [6]. Yeow et al. found that in CT-guided coaxial cutting needle biopsy, lesion depth is the single predictor for risk of pneumothorax [7]. We had the same results, with no pneumothorax complication encountered in tumors close to the thoracic wall. Most TNBs are performed on an outpatient basis by using local anesthesia with or without conscious sedation. Virtually any location in the chest can be safely accessed by means of TNB. Until the interventional radiologists will become interested about TNB, in Romania the thoracic surgeons are performing this procedure.

Conclusion

TNB is generally a safe procedure with limited morbidity and extremely rare mortality. It is an affordable and quick method to obtain histopathological confirmation of intrathoracic tumors. Most TNBs can be performed by using local anesthesia without conscious sedation and virtually any location in the chest can be safely addressed.
Table 3

Complication

No of cases

%

Minor pneumothorax Significant pneumothorax Minor hemoptysis Significant hemoptysis Accidental puncture of the liver                                                  (under fluoroscopy guidance)

14 4 10 1 1

6 2 4 0.5 0.5

  7 in total

1.  Precise biopsy localization by computer tomography.

Authors:  J R Haaga; R J Alfidi
Journal:  Radiology       Date:  1976-03       Impact factor: 11.105

Review 2.  Trans-thoracic biopsy of lung lesions: FNAB or CNB? Our experience and review of the literature.

Authors:  Emanuela Capalbo; Michela Peli; Maria Lovisatti; Maria Cosentino; Paola Mariani; Eisabetta Berti; Maurizio Cariati
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

Review 3.  Management strategy of solitary pulmonary nodules.

Authors:  Ping Zhan; Haiyan Xie; Chunhua Xu; Keke Hao; Zhibo Hou; Yong Song
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

4.  Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions.

Authors:  K M Yeow; L C See; K W Lui; M C Lin; T C Tsao; K F Ng; H P Liu
Journal:  J Vasc Interv Radiol       Date:  2001-11       Impact factor: 3.464

5.  Operating on a suspicious lung mass without a preoperative tissue diagnosis: pros and cons.

Authors:  Alan D L Sihoe; Raj Hiranandani; Henry Wong; Enoch S L Yeung
Journal:  Eur J Cardiothorac Surg       Date:  2013-01-08       Impact factor: 4.191

6.  Transthoracic imaging-guided biopsy of lung lesions: evaluation of benign non-specific pathologic diagnoses.

Authors:  Nantaka Kiranantawat; Narapong Srisala; Jitpreedee Sungsiri; Sarayut L Geater; Wiwatana Tanomkiat
Journal:  J Med Assoc Thai       Date:  2015-05

7.  Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.

Authors:  Rita Nizzoli; Marcello Tiseo; Francesco Gelsomino; Marco Bartolotti; Maria Majori; Lilia Ferrari; Massimo De Filippo; Guido Rindi; Enrico Maria Silini; Annamaria Guazzi; Andrea Ardizzoni
Journal:  J Thorac Oncol       Date:  2011-03       Impact factor: 15.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.